The invention describes a process for making compound (2), comprising the step of cyclising diene (3). Compound (2) may be aigialomycin D or a derivative thereof or may be elaborated to make aigialomycin D or derivative thereof. Furthermore compound (2) or derivative thereof can be used in treating cancer or malaria or a microbial infection.
该发明描述了一种制备化合物(2)的过程,其中包括环化二烯(3)的步骤。化合物(2)可以是aigialomycin D或其衍
生物,或者可以进一步加工制备aigialomycin D或其衍
生物。此外,化合物(2)或其衍
生物可用于治疗癌症、疟疾或微
生物感染。